CollPlant

CollPlant

Biotechnologický výzkum

Rehovot, Israel 10 804 sledující uživatelů

Pioneering Regenerative Medicine

O nás

CollPlant is a regenerative and aesthetic medicine company developing innovative technologies and products for tissue regeneration and organ manufacturing. Our revolutionary plant-based technology is the only commercially viable technology for mass production of recombinant human Type I collagen (rhCollagen), which is identical to the collagen produced by the human body. This makes our rhCollagen the ideal building block for regenerative medicine. Leveraging on the unique properties of rhCollagen and biomaterial know-how, we are developing a pipeline of products aimed at 3D bioprinting of tissues and organs and medical aesthetics. Our mission at CollPlant is to deliver ground-breaking products for regenerative medicine that offer the optimal treatment options to patients.

Obor
Biotechnologický výzkum
Velikost společnosti
51 - 200 zaměstnanců
Ústředí
Rehovot, Israel
Typ
Veřejná společnost
Datum založení
2004
Speciality
Biomaterials, Tissue Engineering, 3D Bio-printing, Medical aesthetics, Collagen, bioprinting a bioink

Lokality

Zaměstnanci společnosti CollPlant

Aktualizace

Podobné stránky

Financování

CollPlant Celkem 10 kol

Poslední kolo

Kapitál post IPO

35 000 000,00 US$

Zobrazit více informací na crunchbase